home img

When it matters,
it matters who you ask.

We’re transforming cancer care by delivering tomorrow’s answers today.

Coming Soon
NEO | Pan Tracer LBxTM

Our new liquid biopsy solution for pan-cancer 
therapy selection.

Biopharma partnerships

NeoGenomics provides unmatched partnership to support pharmaceutical companies, accelerating drug development and clinical trials through a network of College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories. Partner with us for reliable, end-to-end support in bringing life-changing therapies to patients faster. 

Providers

We understand oncology testing

At NeoGenomics, we understand the importance of precision oncology to support oncologists in delivering personalized patient care. That’s why we have developed both broad pan-cancer and disease-state solutions that give you options for obtaining diagnostic data, therapy guidance, and predictive biomarker insights. With regular updates to keep pace with an evolving cancer landscape, our test menu provides capabilities that align to the latest evidence and guidelines.

Precision testing for personalized care

As a leader in oncology diagnostics, we provide an extensive range of over 500 tests covering all major testing modalities, including single-gene molecular testing, immunohistochemistry (IHC), flow cytometry, fluorescence in situ hybridization (FISH), DNA- and RNA-based next-generation sequencing (NGS), and comprehensive genomic profiling (CGP). Whether it’s for solid tumors or hematologic cancers, we offer advanced tissue-based, liquid biopsy, and heme tests to deliver precise and actionable insights for personalized care. 

Partners

Change the cancer therapy landscape

NeoGenomics plays an essential role in helping our biopharma partners accelerate drug development and clinical trials, supporting your mission to save lives through innovation.

The difference is in our data

With just over 2 million patient profiles from over 40,000 unique providers across 4,000 healthcare organizations, we have access to a broad data set that encompasses the diversity of the entire US population. Our multi-modal test menu captures a wide variety of cancer diagnoses and offers supportive insights throughout the patient treatment journey.

Our oncology data solutions can deliver unparalleled insights in precision oncology. 

Patients

Cancer diagnostics that save lives

At NeoGenomics, we understand the importance of finding the best path for you through this challenging time — it’s how we measure success, and what drives us every day. 

Our Patient Support team is here to help you through the complexities of access, billing, insurance, and testing. We can provide educational resources, support, and access to information when you need it most.

Icon lab

Featured tests

Our technology and test offerings are constantly evolving to offer state-of-the-art testing capabilities that align to the latest evidence and guidelines. 

icon people

Client support

NeoGenomics provides unparalleled client support to help providers diagnose and choose the right therapy selection testing to address gaps in cancer care. 

Icon hands

Scientific contributions

With over a decade of experience, NeoGenomics has contributed to a wealth of research, uncovering insights to advance breakthroughs in cancer diagnostics.